Roivant Sciences Ltd Overview
Industry: Biotechnology
Sector: Healthcare
Read MoreReported Results
What the company reported, with filing details kept small.
Quarterly result summary
Stored reported-result values did not pass automated reconciliation.
What changed
- Open the SEC source filing while these values are reprocessed.
Source review
Mavefund has withheld unreconciled figures from the public page.
Earnings release
Open filing
Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.
Other recent earnings materials
SEC filing
10-K
May 20, 2026
SEC filing
8-K
May 20, 2026
SEC filing
8-K
Apr 02, 2026
Earnings release
Earnings release
Feb 06, 2026
SEC filing
10-Q
Feb 06, 2026
SEC filing
8-K
Feb 06, 2026
SEC filing
10-Q
Nov 10, 2025
Earnings release
EXHIBIT 99.1
Nov 10, 2025
SEC filing
8-K
Nov 10, 2025
SEC filing
10-Q
Aug 11, 2025
Prediction-grade evidence
Recent News
Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.
Roivant Sciences Ltd. (ROIV) stock price, news, quote and history
Headline from Yahoo Finance UK: Roivant Sciences Ltd. (ROIV) stock price, news, quote and history.
Roivant Sciences Ltd. (ROIV) stock price, news, quote and history
Headline from Yahoo Finance Singapore: Roivant Sciences Ltd. (ROIV) stock price, news, quote and history.
Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
Headline from Yahoo Finance Singapore: Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026.
Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
Headline from Yahoo Finance: Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026.
Form 4 Roivant Sciences Ltd. For: 21 July By Investing.com
Headline from Investing.com Canada: Form 4 Roivant Sciences Ltd. For: 21 July By Investing.com.
Form 4 Roivant Sciences Ltd. For: 21 July
Headline from Investing.com India: Form 4 Roivant Sciences Ltd. For: 21 July.
Financial Statements
Company-reported SEC EDGAR facts organized into the three core statements.
Verified SEC statements load when this section enters view.
Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.